Twist Bioscience (TWST) Total Non-Current Liabilities (2018 - 2025)

Twist Bioscience (TWST) has disclosed Total Non-Current Liabilities for 5 consecutive years, with $156.1 million as the latest value for Q4 2022.

  • On a quarterly basis, Total Non-Current Liabilities rose 1241.83% to $156.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $156.1 million, a 1241.83% increase, with the full-year FY2022 number at $171.9 million, up 47.95% from a year prior.
  • Total Non-Current Liabilities was $156.1 million for Q4 2022 at Twist Bioscience, down from $171.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $171.9 million in Q3 2022 to a low of -$822.7 million in Q2 2022.
  • A 5-year average of $11.7 million and a median of $60.5 million in 2020 define the central range for Total Non-Current Liabilities.
  • Biggest YoY gain for Total Non-Current Liabilities was 1241.83% in 2022; the steepest drop was 902.1% in 2022.
  • Twist Bioscience's Total Non-Current Liabilities stood at $25.5 million in 2018, then surged by 248.9% to $89.1 million in 2019, then plummeted by 31.04% to $61.4 million in 2020, then crashed by 122.26% to -$13.7 million in 2021, then skyrocketed by 1241.83% to $156.1 million in 2022.
  • Per Business Quant, the three most recent readings for TWST's Total Non-Current Liabilities are $156.1 million (Q4 2022), $171.9 million (Q3 2022), and -$822.7 million (Q2 2022).